DAFNA CAPITAL MANAGEMENT LLC Neurocrine Biosciences, Inc. Transaction History

DAFNA CAPITAL MANAGEMENT LLC portfolio value:

$8.51M
portfolio value

DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -3.02% -2.5K shares 456K $106.21 80.15K
Q2 2022 share Decrease -1.20% -1K shares 214K $97.48 82.65K
Q1 2022 share 0.00% 0 shares 718K $93.75 83.65K
Q4 2021 share Decrease -1.18% -1K shares -994K $84.63 83.65K
Q3 2021 share Increase +14.93% 11K shares 951K $95.91 84.65K
Q2 2021 share 0.00% 0 shares 5K $97.32 73.65K
Q1 2021 share Decrease -20.12% -18.55K shares -1.67M $97.25 73.65K
Q4 2020 share Increase +2.22% 2K shares 164K $95.85 92.20K
Q3 2020 share Increase +23.22% 17K shares -257K $96.16 90.20K
Q2 2020 share Decrease -8.73% -7K shares 1.98M $122 73.20K
Q1 2020 share Increase +31.47% 19.2K shares 384K $86.55 80.20K
Q4 2019 share Decrease -5.43% -3.5K shares 745K $107.49 61.00K
Q3 2019 share Decrease -0.15% -100 shares 358K $90.11 64.50K
Q2 2019 share Increase +17.45% 9.6K shares 609K $84.43 64.60K
Q1 2019 share 0.00% 0 shares 918K $88.1 55.00K
Q4 2018 share Increase +34.14% 14K shares -1.11M $71.41 55.00K
Q3 2018 share Decrease -9.89% -4.5K shares 571K $122.95 41.00K
Q2 2018 share Decrease -16.51% -9K shares -49K $98.24 45.50K
Q1 2018 share 0.00% 0 shares 291K $82.93 54.50K
Q4 2017 share 0.00% 0 shares 889K $77.59 54.50K
Q3 2017 share 0.00% 0 shares 833K $61.28 54.50K
Q2 2017 share Decrease -6.84% -4K shares -26K $46 54.50K
Q1 2017 share Decrease -11.36% -7.5K shares -22K $43.3 58.50K
Q4 2016 share Increase +3.12% 2K shares -686K $38.7 66.00K
Q3 2016 share Decrease -15.22% -11.49K shares -191K $50.64 64.00K
Q2 2016 share Decrease -1.04% -797 shares 414K $45.45 75.50K
Q1 2016 share Increase 0.00% 76.3K shares 3.01M $39.55 76.3K